The unsustainability of clinical trials and need for transformative change
With pressures only intensifying on clinical trials, there are major concerns that current models are inefficient and unsustainable. Insight from…
With pressures only intensifying on clinical trials, there are major concerns that current models are inefficient and unsustainable. Insight from…
The evolving mRNA landscape has been marked by rapid advancements and a broadening scope of applications, primarily driven by the…
Contract development and manufacturing organisations (CDMOs) worldwide are facing a multitude of challenges, which are heightened considerably in oncology by…
Handing over your molecule is a big step for emerging biotechs. The process of developing new drugs is complex and…
Pharmacovigilance plays a crucial role in drug safety and is defined here as the science behind the detection, assessment, understanding,…
Cell and gene therapies (CGT) offer hope to patients living with life-threatening conditions where limited treatment options may be available…
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
Early stage biotech companies (biotechs) rely heavily on external funding to advance their research and development (R&D) programs. Robust fundraising…
According to a comprehensive overview, recruitment challenges are among the most persistent barriers to timely trial completion, often leading to…
Cell and gene therapies represent a groundbreaking advancement in medical science, offering transformative opportunities for treating complex and previously untreatable…